| Morphological criteria to distinguish cell death induced by apoptotic and necrotic treatments S Rello, JC Stockert, VL Moreno, A Gamez, M Pacheco, A Juarranz, ... Apoptosis 10, 201-208, 2005 | 389 | 2005 |
| PTRF/cavin-1 and MIF proteins are identified as non-small cell lung cancer biomarkers by label-free proteomics A Gámez-Pozo, I Sánchez-Navarro, E Calvo, MT Agulló-Ortuño, ... PloS one 7 (3), e33752, 2012 | 99 | 2012 |
| MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in advanced renal cell carcinoma patients A Gámez-Pozo, LM Antón-Aparicio, C Bayona, P Borrega, MIG Sancho, ... Neoplasia 14 (12), 1144-IN14, 2012 | 90 | 2012 |
| A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses G Prado-Vázquez, A Gámez-Pozo, L Trilla-Fuertes, JM Arevalillo, ... Scientific reports 9 (1), 1538, 2019 | 80 | 2019 |
| Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues. I Sánchez-Navarro, A Gámez-Pozo, M González-Barón, Á Pinto-Marín, ... Biotechniques 48 (5), 389, 2010 | 78 | 2010 |
| Combined label-free quantitative proteomics and microRNA expression analysis of breast cancer unravel molecular differences with clinical implications A Gámez-Pozo, J Berges-Soria, JM Arevalillo, P Nanni, R López-Vacas, ... Cancer research 75 (11), 2243-2253, 2015 | 66 | 2015 |
| DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification CV Díaz-García, A Agudo-Lopez, C Perez, JA Lopez-Martin, ... Carcinogenesis 34 (5), 1031-1038, 2013 | 60 | 2013 |
| Functional proteomics outlines the complexity of breast cancer molecular subtypes A Gámez-Pozo, L Trilla-Fuertes, J Berges-Soria, N Selevsek, ... Scientific Reports 7 (1), 10100, 2017 | 54 | 2017 |
| Metaphase arrest and cell death induced by etoposide on HeLa cells S Rello-Varona, A Gámez, V Moreno, JC Stockert, J Cristóbal, M Pacheco, ... The international journal of biochemistry & cell biology 38 (12), 2183-2195, 2006 | 49 | 2006 |
| Protein phosphorylation analysis in archival clinical cancer samples by shotgun and targeted proteomics approaches A Gámez-Pozo, I Sánchez-Navarro, E Calvo, E Díaz, M Miguel-Martín, ... Molecular BioSystems 7 (8), 2368-2374, 2011 | 47 | 2011 |
| MALDI profiling of human lung cancer subtypes A Gamez-Pozo, I Sanchez-Navarro, M Nistal, E Calvo, R Madero, E Diaz, ... PLoS One 4 (11), e7731, 2009 | 43 | 2009 |
| Gene signatures in breast cancer: current and future uses EE Arranz, JÁF Vara, A Gámez-Pozo, P Zamora Translational oncology 5 (6), 398-403, 2012 | 37 | 2012 |
| Shotgun proteomics of archival triple‐negative breast cancer samples A Gámez‐Pozo, NI Ferrer, E Ciruelos, R López‐Vacas, FG Martínez, ... PROTEOMICS–Clinical Applications 7 (3-4), 283-291, 2013 | 36 | 2013 |
| Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics A Gámez-Pozo, L Trilla-Fuertes, G Prado-Vázquez, C Chiva, ... PLoS One 12 (6), e0178296, 2017 | 33 | 2017 |
| An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer I Sánchez-Navarro, A Gámez-Pozo, Á Pinto, D Hardisson, R Madero, ... BMC cancer 10, 1-10, 2010 | 33 | 2010 |
| The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapy A Gamez-Pozo, RM Perez Carrion, L Manso, C Crespo, C Mendiola, ... PloS one 9 (10), e109611, 2014 | 32 | 2014 |
| Comparison of prognostic gene profiles using qRT-PCR in paraffin samples: a retrospective study in patients with early breast cancer E Espinosa, I Sanchez-Navarro, A Gamez-Pozo, AP Marin, D Hardisson, ... PloS one 4 (6), e5911, 2009 | 27 | 2009 |
| Urothelial cancer proteomics provides both prognostic and functional information G de Velasco, L Trilla-Fuertes, A Gamez-Pozo, M Urbanowicz, ... Scientific Reports 7 (1), 15819, 2017 | 26 | 2017 |
| Molecular characterization of breast cancer cell response to metabolic drugs L Trilla-Fuertes, A Gámez-Pozo, JM Arevalillo, M Díaz-Almirón, ... Oncotarget 9 (11), 9645, 2018 | 24 | 2018 |
| Isotopologue multipoint calibration for proteomics biomarker quantification in clinical practice C Chiva, O Pastor, L Trilla-Fuertes, A Gamez-Pozo, JA Fresno Vara, ... Analytical Chemistry 91 (8), 4934-4938, 2019 | 23 | 2019 |
Juan Ángel Fresno VaraInstituto de Genética Médica y Molecular- INGEMM. Hospital Universitario La Paz-IdiPAZยืนยันอีเมลแล้วที่ salud.madrid.org